1. Home
  2. SHIP vs HELP Comparison

SHIP vs HELP Comparison

Compare SHIP & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seanergy Maritime Holdings Corp.

SHIP

Seanergy Maritime Holdings Corp.

HOLD

Current Price

$11.97

Market Cap

281.9M

ML Signal

HOLD

HELP

Cybin Inc. Common Stock

N/A

Current Price

$4.53

Market Cap

281.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SHIP
HELP
Founded
2008
N/A
Country
Greece
Canada
Employees
N/A
50
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
281.9M
281.4M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
SHIP
HELP
Price
$11.97
$4.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$17.00
$95.00
AVG Volume (30 Days)
273.3K
1.1M
Earning Date
02-17-2026
07-01-2026
Dividend Yield
3.47%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.79
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.34
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.79
$4.41
52 Week High
$14.93
$8.55

Technical Indicators

Market Signals
Indicator
SHIP
HELP
Relative Strength Index (RSI) 43.07 35.50
Support Level $7.85 $4.47
Resistance Level $14.93 $4.95
Average True Range (ATR) 0.63 0.34
MACD -0.18 -0.03
Stochastic Oscillator 5.45 7.19

Price Performance

Historical Comparison
SHIP
HELP

About SHIP Seanergy Maritime Holdings Corp.

Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Blueship, Meiship, Kaizenship, Iconship, Titanship, Flagship, Paroship, Worldship, Hellasship, Partnership, Championship, Patriotship, Dukeship, Honorship, Fellowship, Knightship, Lordship, Premiership, Squireship, and Friendship.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc is a clinical-stage pharmaceutical company developing proprietary novel serotonergic agonists (NSAs), which are synthetic molecules designed to activate serotonin pathways associated with neuroplasticity. These compounds are being investigated for potential use in the treatment of depression, anxiety, and other mental health conditions, areas where there is an unmet medical need. It aims to provide treatments designed for mental health disorders. The company is currently developing HLP003, a proprietary NSA, in Phase 3 clinical development for the adjunctive treatment of substantial depressive disorder. It operates in Canada, the United States, the United Kingdom, and Ireland.

Share on Social Networks: